Skip to main content
Redox Biology logoLink to Redox Biology
. 2023 Oct 4;67:102917. doi: 10.1016/j.redox.2023.102917

Glutathione and peroxisome redox homeostasis

Maria J Ferreira a,b,c, Tony A Rodrigues a,b,c,1, Ana G Pedrosa a,b,c,1, Ana R Silva a, Beatriz G Vilarinho a, Tânia Francisco a,b,c,∗∗, Jorge E Azevedo a,b,c,
PMCID: PMC10565873  PMID: 37804696

Abstract

Despite intensive research on peroxisome biochemistry, the role of glutathione in peroxisomal redox homeostasis has remained a matter of speculation for many years, and only recently has this issue started to be experimentally addressed. Here, we summarize and compare data from several organisms on the peroxisome-glutathione topic. It is clear from this comparison that the repertoire of glutathione-utilizing enzymes in peroxisomes of different organisms varies widely. In addition, the available data suggest that the kinetic connectivity between the cytosolic and peroxisomal pools of glutathione may also be different in different organisms, with some possessing a peroxisomal membrane that is promptly permeable to glutathione whereas in others this may not be the case. However, regardless of the differences, the picture that emerges from all these data is that glutathione is a crucial component of the antioxidative system that operates inside peroxisomes in all organisms.

Keywords: Glutathione, Peroxisomes, Redox homeostasis, Membrane permeability, Antioxidant

Graphical abstract

Image 1

Highlights

  • The protein repertoire of GSH-dependent peroxisomal enzymes in different organisms varies widely.

  • Different organisms may use different strategies to maintain a reduced pool of GSH inside peroxisomes.

  • Despite all the differences, GSH is a crucial component of the peroxisomal antioxidant system in all organisms.

1. Introduction

Glutathione is the most abundant low-molecular weight thiol-containing metabolite in the majority of organisms [1,2]. Besides participating in the biogenesis of iron-sulfur proteins and in the detoxification of a myriad of electrophilic metabolites and drugs, glutathione is also a key antioxidant molecule used by a variety of enzymes to neutralize reactive oxygen species (ROS) and to control the redox state of cysteine residues in proteins [2,3]. In many of these reactions, the reduced form of glutathione (GSH) is oxidized to glutathione disulfide (GSSG) which is then subsequently converted to GSH by a NADPH-dependent glutathione reductase ([3,4]; see Fig. 1).

Fig. 1.

Fig. 1

– The functions of glutathione. Glutathione, the most abundant thiol in most organisms, plays a role in multiple pathways/processes such as iron-sulfur (Fe–S) cluster biogenesis and transport (yellow), detoxification of electrophilic substances (blue) and hydroperoxides (purple) and protein deglutathionylation (pink). In many of these reactions, reduced glutathione (GSH) is oxidized to GSSG, which must then be reduced back to GSH by the NADPH-dependent glutathione reductase (green). ROOH and ROH, organic hydroperoxides and the corresponding alcohols, respectively; Protein-SG and Protein-SH, glutathionylated and reduced protein, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Glutathione is exclusively synthesized in the cytosol of non-plant eukaryotic cells where its concentration reaches millimolar levels [[5], [6], [7], [8]]. Despite its cytosolic origin, glutathione is also found in the lumen of several subcellular organelles. The mechanisms that allow organelles to acquire cytosolic glutathione are still unclear [7,9]. Nevertheless, it is known that in some cases GSH and/or GSSG do not diffuse freely across the corresponding membranes, thus leading to situations in which the cytosolic and organelle pools of glutathione are not in redox equilibrium. One of these cases is the endoplasmic reticulum (ER), the membrane of which is permeable to GSH but less so to GSSG [[10], [11], [12]]. Thus, any GSSG produced in the ER lumen (e.g., in ROS-scavenging and thiol-disulfide exchange reactions; [12,13]) is not promptly exported to the cytosol where it would be reduced by cytosolic glutathione reductase [11,13]. Ultimately, this leads to an increase of the GSSG/GSH ratio in the ER lumen thus reflecting and/or controlling the oxidative environment that is required for disulfide bond formation in proteins that follow the secretory pathway (reviewed in Ref. [14]). Another case regards the mitochondrial matrix. Indeed, the mitochondrial inner membrane displays a very restricted permeability to GSH/GSSG, and thus the mitochondrial matrix pools of GSH and GSSG are essentially kinetically independent of the cytosolic ones [7,15,16]. In this case, however, there are no obstacles to the reduction of GSSG because there is a NADPH-dependent glutathione reductase in the mitochondrial matrix [3].

The situation regarding peroxisomes is now starting to be explored. It was long known that glutathione plays some role in the lumen of these organelles in all organisms characterized up to now, including yeasts, plants, and mammals. However, the question of whether the peroxisomal pool of glutathione is kinetically insulated from the cytosolic one remained unexplored until recently. Strikingly, there is no single answer for this question. Indeed, the available data suggest that in some organisms the peroxisomal and glutathione pools may display poor kinetic connectivity, whereas in others this seems not to be the case. Knowledge on this and other aspects of glutathione biology (e.g., the glutathione-dependent enzyme repertoire inside peroxisomes) is of crucial importance for our understanding of how peroxisomes maintain redox homeostasis and keep their cysteine-containing proteins in an active state. Here, we discuss recent findings on this topic giving an emphasis to the mammalian peroxisome.

2. The mammalian peroxisomal matrix is a reducing compartment

Peroxisomes are characterized by an abundance of hydrogen peroxide (H2O2)-producing oxidases [17]. In mammals, these oxidases participate in several metabolic pathways (e.g., fatty acid β-oxidation, d-amino acid oxidation, and polyamine catabolism; [18]) and may produce massive amounts of H2O2, particularly in the liver [17]. Indeed, it has been estimated that, at least in some species, 20% of the O2 consumed by this organ may be channeled into these peroxisomal oxidases [17]. Hydrogen peroxide is a weakly reactive ROS but it can nevertheless modify proteins directly [19]. More importantly, H2O2 can undergo Fenton chemistry generating highly reactive radicals (e.g., hydroxyl and carbonate anion radicals), which in turn can rapidly oxidize virtually any organic molecule [20,21].

To minimize oxidative damage, mammalian peroxisomes contain a small set of antioxidative enzymes (reviewed in Refs. [[22], [23], [24]]). One of these enzymes is catalase, one of the most abundant peroxisomal proteins, comprising 15% of the total protein mass of a liver peroxisome [25]. The other antioxidative enzymes found in mammalian peroxisomes are superoxide dismutase 1 (SOD1; [26]), soluble epoxide hydrolase 2 (sEH; [27]), peroxiredoxin 5 (PRDX5; [28]), and glutathione S-transferase κappa 1 (GSTk1; [29]).

Despite the relatively small repertoire of antioxidative enzymes present in mammalian peroxisomes and the large amounts of H2O2 produced in these organelles, cysteine residues in peroxisomal matrix proteins are maintained as reduced as those of cytosolic proteins, as first assessed using two cysteine-based redox probes, roGFP2 and Redoxfluor [30,31] and subsequentially verified in quantitative redox proteomics analyses [32]. Importantly, it was also shown that transient treatment of cultured cells with strong oxidants leads to reversible alterations in the redox state of peroxisomal matrix protein cysteine residues [30]. Clearly, there are mechanisms to repair oxidized protein cysteine residues in the peroxisomal matrix.

Cysteine residues of cytosolic, mitochondrial, and nucleoplasm proteins are maintained in a reduced state by two enzymatic systems [4,9,33]: 1) the thioredoxin reductase-thioredoxin system, and 2) the glutathione reductase-GSH-glutaredoxin system. Both systems use NADPH to reduce a thiol:disulfide oxidoreductase – a thioredoxin or a glutaredoxin – which in turn reduces oxidized protein cysteine residues (e.g., protein disulfides and mixed disulfides with glutathione). Each reduction cycle results in the oxidation of the oxidoreductase which, therefore, must be reduced again by the upstream component of the system. In the thioredoxin system, the upstream component is thioredoxin reductase, whereas in the glutaredoxin system the reductant is GSH [4,9,33]. As discussed below, mammalian peroxisomes lack glutathione reductase and the same is probably true for thioredoxin reductase [34]. Thus, reducing intraperoxisomal proteins using a thioredoxin-based system would require either the free diffusion of a thioredoxin (a ∼10 kDa protein) across the peroxisomal membrane or a redox relay system to transfer reducing equivalents from cytosolic thioredoxin to some (unknown) luminal thiol:disulfide oxidoreductase, similarly to the situation in the bacterial Dsb disulfide bond formation system [35]. However, there are no data supporting the possibility that the peroxisomal membrane is freely permeable to small proteins, quite the contrary [36], and no peroxisomal transmembrane protein with the potential to act as a redox relay was ever found [[37], [38], [39], [40]].

In contrast to thioredoxins, glutaredoxins are efficiently reduced by GSH [3]. Therefore, a glutaredoxin or a glutaredoxin-like protein residing in the peroxisomal matrix could be reduced by cytosolic GSH, provided that the mammalian peroxisomal membrane is permeable to the GSH/GSSG pair. Evidently, this begs for two questions: 1) is there a glutaredoxin or a glutaredoxin-like protein in the mammalian peroxisomal matrix?; and 2) is the mammalian peroxisomal membrane permeable to GSH/GSSG? We will address these two questions later.

3. Glutathione-dependent enzymes in peroxisomes

The presence of glutathione-dependent enzymes in peroxisomes of several organisms is known for many years ([28,29,41]; see Table 1). Plant peroxisomes seem to have the largest number of this type of enzymes as assessed by proteomic analyses of subcellular fractions highly enriched in peroxisomes and in vivo subcellular localization experiments using fluorescently tagged proteins [[42], [43], [44], [45]]. Although additional work is still needed to confirm some of the available data (see Ref. [46] for a cautionary note on the in vivo subcellular localization experiments performed with the plant proteins), those studies found several glutathione S-transferases in Arabidopsis thaliana peroxisomes, namely members of the theta (GSTT1, GSTT2, and GSTT3), dehydroascorbate reductase (DHAR1), and lambda classes (GSTL2) (see Table 1). Members of the theta family are classical GSTs with both glutathione transferase and peroxidase activities towards hydrophobic electrophiles (e.g., lipid hydroperoxides; [47]) whereas GSTL2 is a monomeric protein displaying glutaredoxin activity ([48,49]; see also [45]). The other GST member, DHAR1, uses GSH to reduce dehydroascorbate to ascorbate, one of the reactions of the glutathione-ascorbate cycle [50]. Interestingly, in addition to DHAR1, other enzymes of this cycle were also found in plant peroxisomes [44], including a small fraction of cytosolic NADPH-dependent glutathione reductase [51].

Table 1.

Antioxidative enzymes found in peroxisomes from plants, fungi, and animals.

ENZYMES PLANTS (Arabidopsis thaliana) FUNGI (Saccharomyces cerevisiae) ANIMALS (Rattus norvegicus) REFERENCES
GLUTATHIONE-DEPENDENT
Glutathione S-transferase theta 1 (GSTT1)
Glutathione S-transferase theta 2 (GSTT2)
Glutathione S-transferase theta 3 (GSTT3)
Glutathione S-transferase lambda 2 (GSTL2)
Dehydroascorbate reductase 1 (DHAR1)
Glutathione S-transferase omega-like 1 (GTO1) Glutathione S-transferase kappa 1 (GSTk1) [29,38,42,45,47,57,121]
Glutathione reductase (GR) Glutathione reductase (GLR1) [51,57]
OTHER:
Cu/Zn superoxide dismutase (CSD3) Cu/Zn superoxide dismutase (SOD1) [26,122,123]
Catalase 1 (CAT1)
Catalase 2 (CAT2)
Catalase 3 (CAT3)
Catalase A (CTA1) Catalase (CAT) [121,[124], [125], [126], [127]]
Epoxide hydrolase 3 (EH3) Epoxide hydrolase 2 (sEH) [121,128,129]
Peroxiredoxin 5 (PRDX5) [28]
Ascorbate peroxidase isoform 3 (APX3)
Ascorbate peroxidase 5 (APX5)
[130]
Monodehydroascorbate reductase isoform 1 (MDAR1) [131]
Monodehydroascorbate reductase isoform 4 (MDAR4) [131]

A simpler situation is found in yeasts (see Table 1 and Fig. 2). Peroxisomes from Candida boidinii contain PMP20, a peroxiredoxin that displays glutathione peroxidase activity [52] and, importantly, peroxisomes from this yeast were shown to contain GSH but no glutathione reductase [52]. Peroxisomes from Saccharomyces cerevisiae also contain GSH/GSSG, as assessed with a peroxisome-targeted sensor of the glutathione redox state [53]. Interestingly, however, the S. cerevisiae orthologue of C. boidinii PMP20, AHP1/TSA II/cTPx III (YLR109W) is probably not a peroxisomal protein [54,55]. Instead, S. cerevisiae peroxisomes contain a GST omega-like 1 protein (GTO1; [56,57]). The presence of GTO1 in S. cerevisiae peroxisomes is of interest because this atypical GST enzyme displays glutaredoxin-like activity ([58]; see also [59] and later). We note that S. cerevisiae peroxisomes were reported to contain also glutathione peroxidases 1 and 3 [60]. However, subcellular localization studies using GFP-fusion proteins do not corroborate this possibility [55,61]. Significantly, and similarly to the situation in plants, S. cerevisiae peroxisomes were recently shown to contain a small fraction of cytosolic NADPH-dependent glutathione reductase [57]. The presence of this enzyme in yeast (and plants; see above) peroxisomes might suggest that the organelle membrane is essentially impermeable to GSSG, similarly to the mitochondrial inner membrane. However, as discussed later, this may not be necessarily so.

Fig. 2.

Fig. 2

– The protective role of glutathione against oxidative damage to protein thiol groups. Glutathione-based enzymatic and non-enzymatic reactions with oxidized proteins are shown. With the exception of yeast OPT2, the identity of all the other peroxisomal glutathione pores/channels remains unknown (“?”). One of these pores might be the peroxisomal protein translocon (purple structures in the membrane), as hypothesized previously [9]. Regardless of their identities and mechanisms of transport (i.e., pore/glutathione-specific transporter, unidirectional/bidirectional), the capacity of glutathione transporters in different organisms may be different, resulting in peroxisomal glutathione pools that may display different degrees of kinetic connectivity with the cytosolic pool. In rat liver, the permeability of the peroxisomal membrane to glutathione is relatively large, as assessed in in vitro experiments [36]. In yeast and plants, the kinetic connectivity of the two pools of glutathione may be low, at least under some physiological conditions, as suggested by the presence of glutathione reductase in their peroxisomes. Hydrogen peroxide oxidizes the thiol group of protein cysteine residues to the sulfenic (-SOH), sulfinic (-SO2H) and sulfonic (-SO3H) derivatives. There are no repair systems for protein sulfonates. Some protein sulfinates can be repaired by sulfiredoxin but this enzyme was never found in peroxisomes. Protein disulfides (-S-S- and -SG) can be reduced by GSH by both enzymatic and non-enzymatic mechanisms (see main text for details). Cyt – cytosol; GR and GRL1 – Glutathione reductase; GSH/GSSG – reduced/oxidized glutathione; GSTk1 – Glutathione S-transferase kappa 1; GSTL2 – Glutathione S-transferase lambda-2; GTO1 – Glutathione S-transferase omega-like 1; Mat – matrix; OPT2 – Oligopeptide transporter 2; SG – glutathionylated protein derivative; SH – reduced protein thiol group; SOH – sulfenic protein derivative; SO2H – sulfinic protein derivative; SO3H – sulfonic protein derivative; S–S – disulfide linked protein. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

The scenario with mammalian peroxisomes is the simplest one (see Fig. 2). Despite numerous biochemical/cell biology studies and proteomic analyses of highly pure liver and kidney peroxisomes performed over the last three decades, only one glutathione-dependent enzyme is presently known in mammalian peroxisomes [29,[37], [38], [39], [40]]. This is the above mentioned GSTk1. GSTk1 displays glutathione transferase and glutathione peroxidase activities in in vitro assays with a few substrates [29,62], a property that has been used to support the idea that GSTk1 may be an antioxidative enzyme [63,64]. In agreement with this, it has been shown that increasing the amount of GSTk1 in peroxisomes of mouse embryonic fibroblasts protects cells from ROS-induced cell death [65]. Very recently it was also proposed that GSTk1 may display glutathione:disulfide oxidoreductase activity ([66]; see later).

It should be noted that glutaredoxin-1 (GLRX1) (and thioredoxin (TXN)) were occasionally identified in the proteomic analyses of mammalian peroxisomes referred to above [[37], [38], [39]]. However, as trace amounts of cytosolic/mitochondrial/ER proteins are always found even in highly pure peroxisome preparations, it is possible that the GLRX1 (and TXN) protein detected in those proteomic analyses represents a cytosolic contamination. Importantly, no glutathione reductase was ever found in proteomic analyses of mammalian peroxisomes [[37], [38], [39], [40]] and accordingly, attempts to detect its activity biochemically in rodent peroxisomes yielded negative results [67]. Thus, any oxidized glutathione eventually produced in the mammalian peroxisomal lumen is probably not reduced in situ.

4. The mammalian peroxisomal membrane is promptly permeable to GSH/GSSG

Peroxisomes import and export a variety of metabolites and cofactors. They do so by 3 different mechanisms (reviewed in Refs. [68,69]). A few enzyme cofactors (e.g., FAD and FMN) are probably co-imported together with the corresponding enzymes (note that peroxisomes can import already folded proteins; see Ref. [70] for a review). Some large/bulky metabolites (e.g., ATP, CoA and acyl-CoAs) are transported by selective channels/transporters [68,69,[71], [72], [73], [74], [75], [76]]. Lastly, small metabolites (e.g., isocitrate, glycerol-3-phosphate) are transported across the peroxisomal membrane by non-selective high-capacity pore-like transporters [68,69]. The exact molecular mass cut-off for these pore-like transporters may be somewhat different in different organisms [68,77]. Nevertheless, an accepted general rule for mammalian peroxisomes is that “solutes with molecular masses up to 300–400 Da” can diffuse freely across the organelle membrane [68] although, as discussed recently, the molecular shape and charge of a solute may also have some weight on this value [69].

Given the permeability characteristics of the mammalian peroxisomal membrane, it has been frequently assumed that GSH (307 Da) simply diffuses freely across the peroxisomal membrane via the non-selective, high-capacity pore-like transporters [24,34]. The fate of intraperoxisomal GSSG (613 Da) remained, for many years, more hypothetical. According to some authors, GSSG could either be reduced in peroxisomes (a hypothesis contingent on the presence of glutathione reductase in the peroxisomal matrix) or somehow exported back into the cytosol [24,34]. Recently, we used a biochemical strategy to address this problem [36]. Using a rat liver post-nuclear supernatant (PNS) containing the glutathione redox sensor PTS2-roGFP2-GLRX1 in both the cytosol and peroxisomes, we found that regardless of its localization, the sensor was rapidly reduced or oxidized when physiological amounts of GSH or GSSG, respectively, were added to the PNS. Furthermore, peroxisomal PTS2-roGFP2-GLRX1 that had been oxidized with GSSG was quickly reduced when the PNS was supplemented with both NADPH and glutathione reductase, thus suggesting that intraperoxisomal GSSG can exit peroxisomes to be reduced in the cytosol. These results suggest that the mammalian peroxisomal membrane is promptly permeable to both GSH and GSSG and, therefore, that the peroxisomal and cytosolic pools of GSH/GSSG are not kinetically insulated. Interestingly, side-by-side comparisons of the reduction/oxidation kinetics of the peroxisomal and cytosolic PTS2-roGFP2-GLRX1 pools revealed slight differences: whereas cytosolic PTS2-roGFP2-GLRX1 equilibrated with cytosolic GSH/GSSG almost instantly, peroxisomal PTS2-roGFP2-GLRX1 required 1–2 min to reach redox equilibrium. This finding explains why peroxisome-cytosol redox gradients can still be detected in metabolically active live cells [30,66], despite the large permeability of the mammalian peroxisomal membrane to GSH/GSSG.

The transporter(s) that allow GSH/GSSG to go across the mammalian peroxisomal membrane remain(s) totally enigmatic. Despite the scarcity of transmembrane proteins in peroxisomes (reviewed in Ref. [69]), mice or mammalian cells lacking one of these proteins or possessing a severe mutation in the corresponding gene do not display signs of a general peroxisome deficiency [69,[78], [79], [80], [81], [82], [83], [84], [85], [86]]. One possibility to explain these findings is that other peroxisomal antioxidant defenses (e.g., catalase) compensate the lack of glutathione in the organelle (see Ref. [36]). It is also possible that there are two or more redundant glutathione transporters in the mammalian peroxisomal membrane and thus only the simultaneous knockout of the relevant genes will reveal a defect in glutathione transport across the peroxisomal membrane. Alternatively, and as proposed several years ago [9], glutathione might enter and exit the organelle (also) through the peroxisomal protein matrix translocon. Although we are still lacking structural information on this multisubunit transmembrane protein complex, the available biochemical data suggest that this translocon forms a large hydrophilic pore in the membrane through which newly synthesized (cytosolic) proteins reach the organelle lumen [87,88]. At first sight, this hypothesis may seem unlikely because all peroxisome-containing organisms possess such a translocon and, as explained above, the peroxisomal membranes of different organisms may display different permeabilities to glutathione. However, in the absence of information regarding the numbers of translocons per organelle in different organisms and the in vivo degree of saturation of the translocon by proteins en route to the peroxisome matrix, this hypothesis remains plausible.

Data on GSH/GSSG peroxisomal transporters in other organisms are likewise very limited. To the best of our knowledge, thus far, only one membrane protein was proposed to transport glutathione across the peroxisomal membrane. This is the S. cerevisiae OPT2 [53], a protein with no orthologue in mammals. Interestingly, it was proposed that OPT2 transports peroxisomal GSSG to the cytosol to be reduced, an idea that at the light of recent data suggesting that yeast peroxisomes contain glutathione reductase [57] might seem unlikely. However, recent work on the yeast Debaryomyces hansenii [89] indicates that, at least in one case, an intraperoxisomal regeneration system for a bulky metabolite can co-exist with a large-capacity membrane transporter for that same metabolite. Indeed, that yeast requires large amounts of NAD+ in the peroxisomal matrix for fatty acid β-oxidation and uses two strategies to achieve this requirement: 1) peroxisomal NADH is converted enzymatically to NAD+ in situ, yielding two small metabolites (malate and glycerol-3-phosphate) that are exported to the cytosol, and 2) peroxisomal NADH is simply exchanged by cytosolic NAD+. Thus, it is possible that peroxisomal GSSG in S. cerevisiae can also follow two pathways: 1) reduction in situ by peroxisomal glutathione reductase and 2) export to the cytosol, where it is reduced by cytosolic glutathione reductase.

5. How are reducing equivalents from GSH conveyed to oxidized protein cysteine residues in the peroxisomal matrix?

As explained above, cysteine residues in mammalian peroxisomal matrix proteins are maintained as reduced as those of cytosolic proteins. The same is true for S. cerevisiae, as assessed from a recent quantitative redox proteomics analysis [90], and measurements of the glutathione redox potential in yeast peroxisomes [53]. We are still lacking redox proteomics data for plant peroxisomes but as the thiol-disulfide redox potential in the matrix of these organelles is similar to that of the cytosol [[91], [92], [93]], an analogous situation may exist in plants. If there is glutathione in the peroxisomal matrix of all organisms, how are its reducing equivalents conveyed to oxidized protein cysteine residues? We are still missing many pieces of the glutathione-peroxisome puzzle to fully understand this aspect of peroxisome biochemistry. Nevertheless, it is probable that both enzymatic and non-enzymatic glutathione-based mechanisms play a role in this process, as discussed below.

5.1. Enzymatic glutathione-based mechanisms

Our knowledge on intraperoxisomal glutathione-based enzymes with the ability to transfer redox equivalents from glutathione to protein thiol groups remains very scarce and limited to the identification of some candidates. As stated above, S. cerevisiae peroxisomes contain GTO1, a monothiol omega-like GST [58]. The importance of GTO1 for yeast metabolism is highlighted by the fact that strains lacking this enzyme grow poorly on media containing oleic acid as an energy source, a condition in which large amounts of H2O2 are produced in the organelle matrix [56]. Yeast GTO1 displays glutaredoxin-like activity in vitro [58], raising the possibility that, similarly to human GST omega-1 [94], it can deglutathionylate protein substrates. Reduction of protein disulfide bonds might also be accomplished by yeast GTO1 either directly (see Ref. [95] for a mechanism of this type) or, more likely, indirectly, after a thiol-disulfide exchange reaction between the protein disulfide and GSH, as described for the reduction of mammalian ribonucleotide reductase by an engineered monothiol glutaredoxin 1 ([96]; reviewed in Ref. [3]).

A similar reasoning can be applied to A. thaliana GSTL2, an atypical monomeric GST that contains a catalytic cysteine residue [48,49]. GSTL2 also displays glutaredoxin-like activity in vitro, and thus, it might be part of the plant peroxisomal machinery that repairs oxidized protein cysteine residues. It is interesting to note that GrxC1, one of the ∼30 glutaredoxins present in A. thaliana [97], possesses a peroxisomal targeting signal type 1 [98,99], although, to the best of our knowledge, this protein was never found in proteomics analyses of plant peroxisomes.

In contrast to yeast GTO1 and plant GSTL2, mammalian GSTk1 lacks a cysteine residue at the active site. Thus, a classical glutaredoxin-like mechanism involving a direct nucleophilic attack of glutathionylated proteins by the enzyme is not possible. However, GSTs are versatile enzymes, and some can disrupt disulfide bonds by using an activated GSH molecule to perform the nucleophilic attack [3,100]. A recent study proposed that this is the case for GSTk1. Indeed, it was found that the presence of GSTk1 in peroxisomes increases the rate at which a peroxisome-targeted roGFP2 protein recovers its reduced state after a strong chemical oxidative insult leading the authors to conclude that GSTk1 possesses glutaredoxin-like activity [66]. Interestingly, however, in agreement with the absence of a peroxisomal phenotype in GSTk1-knockout mice [101], the basal peroxisomal thiol-disulfide redox potential in cells lacking GSTk1 is not altered [66], indicating that there are other mechanisms to keep cysteine residues of peroxisomal matrix proteins in the reduced state.

5.2. Non-enzymatic glutathione-based mechanisms

Although glutathione-based reactions are mostly catalyzed in vivo, glutathione can also participate in spontaneous/direct reactions such as condensation with cysteine sulfenic acids and thiol-disulfide exchange reactions [102]. Aiming at gauging the importance of these non-enzymatic reactions for intraperoxisomal protein redox homeostasis, we have recently developed a kinetic redox model of the mammalian peroxisome [36]. The results obtained suggest that indeed non-enzymatic mechanisms involving GSH are sufficient to protect intraperoxisomal protein cysteine residues from oxidation by H2O2. Even peroxisomal enzymes possessing catalytic cysteine residues, which are expected to be particularly sensitive to H2O2 (e.g., the thiolases ACAA1 and SCPx and the bile acid-CoA:amino acid N-acyltransferase, BAAT) may be protected from H2O2-mediated oxidation by GSH in the absence of thiol:disulfide oxidoreductases. The reason for this counterintuitive conclusion is related to the relative physiological steady-state concentrations of GSH and H2O2 (∼5 mM versus 1–100 nM, respectively; [8,103]) and the rates at which these species react with the sulfenyl derivatives of cysteine residues, the first products of the reaction between a thiol group and H2O2 (see Fig. 3). GSH reacts with cysteine-sulfenic acid at rates of ∼10-105 M−1 s−1 ([102,104]; see also [36]), whereas H2O2 oxidizes protein cysteine-sulfenic acid to cysteine-sulfinic acid (an irreversible cysteine oxidation product in peroxisomes due to the absence of sulfiredoxin in the organelle; [105]) at rates of about 102-104 M−1 s−1 [106,107]. Thus, even if we take the smallest rate constant for the reaction between GSH and cysteine-sulfenic acid (i.e., 10 M−1 s−1) and the largest one for the reaction between H2O2 and cysteine-sulfenic acid (i.e., 104 M−1 s−1), the fact that GSH is 50 000 to 5 000 000-fold more abundant than H2O2 means that most protein sulfenic acids will react preferentially with GSH (yielding a glutathionylated protein) instead of being further oxidized to protein sulfinic acids. Glutathionylated proteins can then be completely reduced by direct reaction with GSH. Although spontaneous thiol-disulfide exchange reactions are relatively slow when compared with those catalyzed by thiol:disulfide oxidoreductases such as glutaredoxin (0.1–10 M−1 s−1 and 104-106 M−1 s−1, respectively; [102]), the large physiological concentration of GSH (∼5 mM; [8]) results in a pseudo-first order rate constant for the non-enzymatic reduction of a glutathionylated protein by GSH of 5x10−4-5x10−2 s−1, which corresponds to a half-life of just 0.23–23 min.

Fig. 3.

Fig. 3

– Non-enzymatic oxidation/reduction kinetics of protein thiol groups in peroxisomes. The half-lives (t1/2) of the different species were calculated assuming peroxisomal steady-state (ss) concentrations of 80 nM and 5 mM for H2O2 and GSH [36], respectively, and the following second order rate constants: oxidation of cysteine (PSH) to sulfenic acid (PSOH) – 2.7 M−1 s−1 for non-catalytic cysteines [104] and 100 M−1 s−1 for active-site cysteine residues ([106]; see also [36]); oxidation of cysteine sulfenic (PSOH) to sulfinic acid (PSO2H) by H2O2 – 102–104 M−1 s−1 [106,107,132]; condensation of cysteine sulfenic acid (PSOH) with the thiol group of GSH – 6.7–105 M−1 s−1 ([102,104]; see also [36]); and thiol-disulfide exchange – 0.1–10 M−1 s−1 [102]. Second-order rate constants were multiplied by the corresponding steady-state concentrations of GSH or H2O2 to obtain pseudo-first order constants (K), and these were converted to half-lives (t1/2 = ln2/K). Red and green colors indicate oxidation and reduction reactions, respectively. GSH – reduced glutathione; H2O2 – hydrogen peroxide; PSH – reduced protein; PSSG – glutathionylated protein; PSOH – protein sulfenic derivative; PSO2H – protein sulfinic derivative. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

6. Glutathione is more important than catalase in protecting peroxisomal protein cysteine residues from H2O2-induced oxidation

Unexpectedly, the kinetic simulations referred to above also revealed that the non-enzyme assisted action of glutathione inside the mammalian peroxisome provides more protection against H2O2 than catalase itself [36]. Indeed, although the absence of catalase in peroxisomes increased the intraperoxisomal H2O2 concentration from ∼80 nM to ∼1 μM, which led to the massive oxidation of peroxisomal matrix proteins, having a peroxisomal membrane permeable to cytosolic glutathione was sufficient to protect intraperoxisomal proteins from H2O2-induced oxidation even in the absence of a glutaredoxin. This does not mean that catalase has a redundant/non-important function inside peroxisomes. By maintaining the intraperoxisomal concentration of H2O2 at low levels, catalase decreases the fraction of H2O2 that can potentially undergo Fenton chemistry. Also, by scavenging most of the H2O2 generated by peroxisomal oxidases, catalase decreases the amount of peroxisomal H2O2 that reaches the cytosol by ∼94% [36], thus sparing NADPH consumption by the cytosolic H2O2-scavenging peroxiredoxin and glutathione peroxidase systems. The amount of NADPH saved by peroxisomal catalase may be quite substantial. For instance, if we extrapolate biochemical data from rat liver (380 nmol of peroxisomal H2O2 produced per gram of liver per min; [108]) to adult humans (liver weight ∼1.5 Kg) and consider that the human liver resting metabolic rate is ∼1/4 that of rat liver [109] we conclude that 0.2 mol of H2O2 are produced every day in human liver peroxisomes. This is equivalent to 230 mL of the 3% (w/v) H2O2 solution that can be acquired in pharmacies. In the absence of peroxisomal catalase, all this H2O2 would reach the cytosol where its neutralization would cost 0.2 mol of NADPH or about 3 g of glucose/day, assuming that all the NADPH derives from the pentose phosphate pathway (1 mol of glucose (180 g) → 12 mol of NADPH). In the presence of catalase only 180 mg of glucose/day are consumed by the cytosolic NADPH-dependent reductive systems.

7. Conclusions and future perspectives

Here, we summarize data on the peroxisome-glutathione relationship. Although our focus was the mammalian peroxisome, data from other organisms were also analyzed. A major conclusion that can be drawn from these comparisons is that data gathered on the glutathione-peroxisome topic in a given organism cannot be easily extrapolated to other organisms. It is long known that peroxisomes are some of the most plastic organelles of the eukaryotic kingdom that can hold widely different enzyme repertoires in different organisms [110,111]. However, some basic functions (e.g., β-oxidation of fatty acids, presence of multiple oxidases and catalase) were mostly conserved throughout evolution [111], and thus the realization that important aspects of glutathione biochemistry in a given organism, are not conserved in others is somewhat unexpected.

Despite all the differences in the glutathione-based enzyme repertoire and, possibly, also in the permeabilities of the peroxisomal membrane to GSH/GSSG, it is evident that all organisms characterized up to now have glutathione in their peroxisomes. This, per se, is important because the available data suggest that the mere presence of glutathione within the organelle is already sufficient to protect peroxisomal proteins from oxidation by H2O2. The protective role of glutathione also offers a straightforward explanation for the fact that humans with acatalasia exhibit essentially no peroxisome-related phenotypes [112], a property that is also true for animal models such as catalase-knockout mice [113]. In principle, the absence of catalase in peroxisomes leads to a massive increase in intraperoxisomal H2O2, which, in turn, should trigger extensive oxidation/inactivation of peroxisomal enzymes [36]. However, no such oxidation/inactivation occurs due to the robust protective effect of glutathione (see Fig. 3; [36]).

In addition to H2O2, other ROS are certainly generated in the peroxisomal matrix or reach the organelle from the cytosol, and these ROS should also be eliminated. Whereas in some cases there are no reasons to believe that glutathione is involved in these defense mechanisms, in others this still needs to be investigated. For reactive species such as superoxide anion and some epoxides, mammalian peroxisomes are equipped with SOD1 and epoxide hydrolase 2 which convert those species into H2O2 and the corresponding vicinal diols, respectively [26,114]. Superoxide anion can also react with glutathione but, in the absence of SOD1, it is unlikely that glutathione plays any protective role against this ROS [115]. Epoxides, however, can also be rapidly conjugated to GSH by several GSTs [3,116] and thus, it would be important to determine whether GSTk1 also displays such an activity. Reactive species like hydroperoxides and peroxynitrite can, in principle, be efficiently neutralized by peroxisomal PRDX5 [[117], [118], [119]]. However, peroxiredoxins such as PRDX5 are generally supported by the thioredoxin system which reduces the oxidized peroxiredoxin at each catalytic cycle [120]. As stated above, no thioredoxin reductase was ever found in mammalian peroxisomes and thus exactly how PRDX5 functions in peroxisomes remains unknown. One possibility to explain this enigma is that oxidized PRDX5 is reduced by GSH [34] but experimental data to support this hypothesis are still lacking.

Many other questions remain on the peroxisome-glutathione topic. An obvious one regards the identity of the transporters that allow GSH/GSSG to go across the peroxisomal membrane. It is expected that a systematic knockout of genes encoding mammalian peroxisomal membrane proteins will soon lead to the identification of such (a) protein(s) [80], although problems may be encountered if the long-sought glutathione transporter is the protein translocon through which newly synthesized proteins are imported into the organelle [9]. Another important issue that remains unclear regards the enzymatic machinery that conveys redox equivalents from intraperoxisomal GSH to protein cysteine residues. Although it seems clear that the simple presence of glutathione in the peroxisomal matrix already provides an efficient protection against H2O2-induced oxidation, other more aggressive ROS may require more robust enzyme-based defenses. Yeast GTO1 and plant GSTL2 are, at present, the best candidates to catalyze glutathione-based repair of oxidized proteins, but experimental data to support this possibility are still lacking. In mammals, it was recently proposed that GSTk1 plays such a role but, likewise, the mechanism used by GSTk1 to maintain protein cysteine residues in the reduced state remains unknown. These and other aspects must be clarified if we are to fully understand the redox homeostasis mechanisms that operate inside the peroxisome.

Authorship

MJF – conceptualization, investigation, writing - original draft, review & editing.

TAR, AGP, ARS, BGV – investigation, writing - review & editing.

TF – conceptualization, investigation, writing - original draft, review & editing.

JEA – conceptualization, investigation, writing - original draft, review & editing, funding acquisition.

All authors have contributed to the manuscript and approved the submitted version.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

We thank Marc Fransen (KU-Leuven) and Tiago Duarte (i3S-Univ. Porto) for critically reading the manuscript.

This work was funded by National Funds through FCT — Fundação para a Ciência e a Tecnologia, I.P., under the projects UIDB/04293/2020, EXPL/BIA-MOL/1664/2021 “Investigating the molecular mechanisms of mammalian pexophagy” and 2022.08378.PTDC “A new component of the mammalian peroxisomal protein import machinery”, funded by FEDER (Fundo Europeu de Desenvolvimento Regional), through COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through Fundação para a Ciência e Tecnologia (FCT)/Ministério da Ciência, Tecnologia e Ensino Superior in the framework of the projects: “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274), and through Norte 2020 - Programa Operacional Regional do Norte, under the application of the “Porto Neurosciences and Neurologic Disease Research Initiative at i3S” (NORTE-01-0145-FEDER-000008). MJF, TAR, AGP, ARS and TF are supported by Fundação para a Ciência e Tecnologia, Programa Operacional Potencial Humano do QREN and Fundo Social Europeu."

Contributor Information

Tânia Francisco, Email: taniaf@ibmc.up.pt.

Jorge E. Azevedo, Email: jazevedo@ibmc.up.pt.

Data availability

No data was used for the research described in the article.

References

  • 1.Meister A., Anderson M.E. Glutathione., Annu. Rev. Biochem. 1983;52:711–760. doi: 10.1146/annurev.bi.52.070183.003431. [DOI] [PubMed] [Google Scholar]
  • 2.Cassier-Chauvat C., Marceau F., Farci S., Ouchane S., Chauvat F. The glutathione system: a journey from cyanobacteria to higher eukaryotes. Antioxidants. 2023;12 doi: 10.3390/antiox12061199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Deponte M. Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim. Biophys. Acta Gen. Subj. 2013;1830:3217–3266. doi: 10.1016/j.bbagen.2012.09.018. [DOI] [PubMed] [Google Scholar]
  • 4.Couto N., Wood J., Barber J. The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radic. Biol. Med. 2016;95:27–42. doi: 10.1016/j.freeradbiomed.2016.02.028. [DOI] [PubMed] [Google Scholar]
  • 5.Lu S.C. Glutathione synthesis. Biochim. Biophys. Acta. 2013;1830:3143–3153. doi: 10.1016/j.bbagen.2012.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Noctor G., Mhamdi A., Chaouch S., Han Y., Neukermans J., Marquez-Garcia B., Queval G., Foyer C.H. Glutathione in plants: an integrated overview. Plant Cell Environ. 2012;35:454–484. doi: 10.1111/j.1365-3040.2011.02400.x. [DOI] [PubMed] [Google Scholar]
  • 7.Oestreicher J., Morgan B. Glutathione: subcellular distribution and membrane transport 1. Biochem. Cell. Biol. 2019;97:270–289. doi: 10.1139/bcb-2018-0189. [DOI] [PubMed] [Google Scholar]
  • 8.Vázquez-Meza H., Vilchis-Landeros M.M., Vázquez-Carrada M., Uribe-Ramírez D., Matuz-Mares D. Cellular compartmentalization, glutathione transport and its relevance in some pathologies. Antioxidants. 2023;12:834. doi: 10.3390/antiox12040834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Deponte M. The incomplete glutathione puzzle: just guessing at numbers and Figures? Antioxidants Redox Signal. 2017;27:1130–1161. doi: 10.1089/ars.2017.7123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lizák B., Birk J., Zana M., Kosztyi G., V Kratschmar D., Odermatt A., Zimmermann R., Geiszt M., Appenzeller-Herzog C., Bánhegyi G. Ca2+ mobilization-dependent reduction of the endoplasmic reticulum lumen is due to influx of cytosolic glutathione. BMC Biol. 2020;18:19. doi: 10.1186/s12915-020-0749-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bánhegyi G., Lusini L., Puskás F., Rossi R., Fulceri R., Braun L., Mile V., di Simplicio P., Mandl J., Benedetti A. Preferential transport of glutathione versus glutathione disulfide in rat liver microsomal vesicles. J. Biol. Chem. 1999;274:12213–12216. doi: 10.1074/jbc.274.18.12213. [DOI] [PubMed] [Google Scholar]
  • 12.Delaunay-Moisan A., Appenzeller-Herzog C. The antioxidant machinery of the endoplasmic reticulum: protection and signaling. Free Radic. Biol. Med. 2015;83:341–351. doi: 10.1016/j.freeradbiomed.2015.02.019. [DOI] [PubMed] [Google Scholar]
  • 13.Jessop C.E., Bulleid N.J. Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 2004;279:55341–55347. doi: 10.1074/jbc.M411409200. [DOI] [PubMed] [Google Scholar]
  • 14.Appenzeller-Herzog C. Glutathione- and non-glutathione-based oxidant control in the endoplasmic reticulum. J. Cell Sci. 2011;124:847–855. doi: 10.1242/jcs.080895. [DOI] [PubMed] [Google Scholar]
  • 15.Kojer K., Bien M., Gangel H., Morgan B., Dick T.P., Riemer J. Glutathione redox potential in the mitochondrial intermembrane space is linked to the cytosol and impacts the Mia40 redox state. EMBO J. 2012;31:3169–3182. doi: 10.1038/emboj.2012.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Booty L.M., Gawel J.M., Cvetko F., Caldwell S.T., Hall A.R., Mulvey J.F., James A.M., Hinchy E.C., Prime T.A., Arndt S., Beninca C., Bright T.P., Clatworthy M.R., Ferdinand J.R., Prag H.A., Logan A., Prudent J., Krieg T., Hartley R.C., Murphy M.P. Selective disruption of mitochondrial thiol redox state in cells and in vivo. Cell Chem. Biol. 2019;26:449–461. doi: 10.1016/j.chembiol.2018.12.002. e8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.De Duve C., Baudhuin P. Peroxisomes (microbodies and related particles) Physiol. Rev. 1966;46:323–357. doi: 10.1152/physrev.1966.46.2.323. [DOI] [PubMed] [Google Scholar]
  • 18.Wanders R.J.A., Baes M., Ribeiro D., Ferdinandusse S., Waterham H.R. The physiological functions of human peroxisomes. Physiol. Rev. 2023;103:957–1024. doi: 10.1152/PHYSREV.00051.2021. [DOI] [PubMed] [Google Scholar]
  • 19.Paulsen C.E., Carroll K.S. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem. Rev. 2013;113:4633–4679. doi: 10.1021/cr300163e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Winterbourn C.C. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 1995;82–83:969–974. doi: 10.1016/0378-4274(95)03532-x. [DOI] [PubMed] [Google Scholar]
  • 21.Meyerstein D. Re-Examining Fenton and fenton-like reactions. Nat. Rev. Chem. 2021;5:595–597. doi: 10.1038/s41570-021-00310-4. [DOI] [PubMed] [Google Scholar]
  • 22.Fransen M., Lismont C. Redox signaling from and to peroxisomes: progress, challenges and prospects. Antioxidants Redox Signal. 2018:7515. doi: 10.1089/ars.2018.7515. ars.2018. [DOI] [PubMed] [Google Scholar]
  • 23.a Bonekamp N., Völkl A., Fahimi H.D., Schrader M. Reactive oxygen species and peroxisomes: struggling for balance. Biofactors. 2009;35:346–355. doi: 10.1002/biof.48. [DOI] [PubMed] [Google Scholar]
  • 24.Fransen M., Nordgren M., Wang B., Apanasets O. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim. Biophys. Acta. 2012;1822:1363–1373. doi: 10.1016/j.bbadis.2011.12.001. [DOI] [PubMed] [Google Scholar]
  • 25.Leighton F., Poole B., Lazarow P.B., De Duve C. The synthesis and turnover of rat liver peroxisomes. I. Fractionation of peroxisome proteins. J. Cell Biol. 1969;41:521–535. doi: 10.1083/jcb.41.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Islinger M., Li K.W., Seitz J., Völkl A., Lüers G.H. Hitchhiking of Cu/Zn superoxide dismutase to peroxisomes--evidence for a natural piggyback import mechanism in mammals. Traffic. 2009;10:1711–1721. doi: 10.1111/j.1600-0854.2009.00966.x. [DOI] [PubMed] [Google Scholar]
  • 27.Luo B., Norris C., Bolstad E.S.D., Knecht D.A., Grant D.F. Protein quaternary structure and expression levels contribute to peroxisomal-targeting-sequence-1-mediated peroxisomal import of human soluble epoxide hydrolase. J. Mol. Biol. 2008;380:31–41. doi: 10.1016/j.jmb.2008.04.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yamashita H., Avraham S., Jiang S., London R., Van Veldhoven P.P., Subramani S., Rogers R.A., Avraham H. Characterization of human and murine PMP20 peroxisomal proteins that exhibit antioxidant activity in vitro. J. Biol. Chem. 1999;274:29897–29904. doi: 10.1074/jbc.274.42.29897. [DOI] [PubMed] [Google Scholar]
  • 29.Morel F., Rauch C., Petit E., Piton A., Theret N., Coles B., Guillouzo A. Gene and protein characterization of the human glutathione S -transferase kappa and evidence for a peroxisomal localization. J. Biol. Chem. 2004;279:16246–16253. doi: 10.1074/jbc.M313357200. [DOI] [PubMed] [Google Scholar]
  • 30.Ivashchenko O., Van Veldhoven P.P., Brees C., Ho Y.-S., Terlecky S.R., Fransen M. Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk. Mol. Biol. Cell. 2011;22:1440–1451. doi: 10.1091/mbc.E10-11-0919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yano T., Oku M., Akeyama N., Itoyama A., Yurimoto H., Kuge S., Fujiki Y., Sakai Y. A novel fluorescent sensor protein for visualization of redox states in the cytoplasm and in peroxisomes. Mol. Cell Biol. 2010;30:3758–3766. doi: 10.1128/MCB.00121-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Xiao H., Jedrychowski M.P., Schweppe D.K., Huttlin E.L., Yu Q., Heppner D.E., Li J., Long J., Mills E.L., Szpyt J., He Z., Du G., Garrity R., Reddy A., Vaites L.P., Paulo J.A., Zhang T., Gray N.S., Gygi S.P., Chouchani E.T. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell. 2020;180:968–983. doi: 10.1016/j.cell.2020.02.012. e24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Go Y.-M., Jones D.P. Redox control systems in the nucleus: mechanisms and functions. Antioxidants Redox Signal. 2010;13:489–509. doi: 10.1089/ars.2009.3021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Antonenkov V.D., Grunau S., Ohlmeier S., Hiltunen J.K. Peroxisomes are oxidative organelles. Antioxidants Redox Signal. 2010;13:525–537. doi: 10.1089/ars.2009.2996. [DOI] [PubMed] [Google Scholar]
  • 35.Manta B., Boyd D., Berkmen M. Disulfide bond formation in the periplasm of Escherichia coli. EcoSal Plus. 2019;8 doi: 10.1128/ecosalplus.ESP-0012-2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ferreira M.J., Rodrigues T.A., Pedrosa A.G., Gales L., Salvador A., Francisco T., Azevedo J.E. The mammalian peroxisomal membrane is permeable to both GSH and GSSG - implications for intraperoxisomal redox homeostasis. Redox Biol. 2023;63 doi: 10.1016/j.redox.2023.102764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gronemeyer T., Wiese S., Ofman R., Bunse C., Pawlas M., Hayen H., Eisenacher M., Stephan C., Meyer H.E., Waterham H.R., Erdmann R., Wanders R.J., Warscheid B. The proteome of human liver peroxisomes: identification of five new peroxisomal constituents by a label-free quantitative proteomics survey. PLoS One. 2013;8 doi: 10.1371/journal.pone.0057395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wiese S., Gronemeyer T., Ofman R., Kunze M., Grou C.P., Almeida J.A., Eisenacher M., Stephan C., Hayen H., Schollenberger L., Korosec T., Waterham H.R., Schliebs W., Erdmann R., Berger J., Meyer H.E., Just W., Azevedo J.E., Wanders R.J.A., Warscheid B. Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. Mol. Cell. Proteomics. 2007;6:2045–2057. doi: 10.1074/mcp.M700169-MCP200. [DOI] [PubMed] [Google Scholar]
  • 39.Islinger M., Lüers G.H., Li K.W., Loos M., Völkl A. Rat liver peroxisomes after fibrate treatment. A survey using quantitative mass spectrometry. J. Biol. Chem. 2007;282:23055–23069. doi: 10.1074/jbc.M610910200. [DOI] [PubMed] [Google Scholar]
  • 40.Kikuchi M., Hatano N., Yokota S., Shimozawa N., Imanaka T., Taniguchi H. Proteomic analysis of rat liver peroxisome. Presence of peroxisome-specific isozyme of Lon protease. J. Biol. Chem. 2004;279:421–428. doi: 10.1074/jbc.M305623200. [DOI] [PubMed] [Google Scholar]
  • 41.Jimenez A., Hernandez J.A., Del Rio L.A., Sevilla F. Evidence for the presence of the ascorbate-glutathione cycle in mitochondria and peroxisomes of pea leaves. Plant Physiol. 1997;114:275–284. doi: 10.1104/pp.114.1.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Reumann S., Quan S., Aung K., Yang P., Manandhar-Shrestha K., Holbrook D., Linka N., Switzenberg R., Wilkerson C.G., Weber A.P.M., Olsen L.J., Hu J. In-depth proteome analysis of Arabidopsis leaf peroxisomes combined with in vivo subcellular targeting verification indicates novel metabolic and regulatory functions of peroxisomes. Plant Physiol. 2009;150:125–143. doi: 10.1104/pp.109.137703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Corpas F.J., González-Gordo S., Palma J.M. Plant peroxisomes: a factory of reactive species. Front. Plant Sci. 2020;11:853. doi: 10.3389/fpls.2020.00853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pan R., Reumann S., Lisik P., Tietz S., Olsen L.J., Hu J. Proteome analysis of peroxisomes from dark-treated senescent Arabidopsis leaves. J. Integr. Plant Biol. 2018;60:1028–1050. doi: 10.1111/jipb.12670. [DOI] [PubMed] [Google Scholar]
  • 45.Dixon D.P., Hawkins T., Hussey P.J., Edwards R. Enzyme activities and subcellular localization of members of the Arabidopsis glutathione transferase superfamily. J. Exp. Bot. 2009;60:1207–1218. doi: 10.1093/jxb/ern365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Falter C., Thu N.B.A., Pokhrel S., Reumann S. New guidelines for fluorophore application in peroxisome targeting analyses in transient plant expression systems. J. Integr. Plant Biol. 2019;61:884–899. doi: 10.1111/jipb.12791. [DOI] [PubMed] [Google Scholar]
  • 47.Wagner U., Edwards R., Dixon D.P., Mauch F. Probing the diversity of the Arabidopsis glutathione S-transferase gene family. Plant Mol. Biol. 2002;49:515–532. doi: 10.1023/a:1015557300450. [DOI] [PubMed] [Google Scholar]
  • 48.Dixon D.P., Edwards R. Roles for stress-inducible lambda glutathione transferases in flavonoid metabolism in plants as identified by ligand fishing. J. Biol. Chem. 2010;285:36322–36329. doi: 10.1074/jbc.M110.164806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Dixon D.P., Davis B.G., Edwards R. Functional divergence in the glutathione transferase superfamily in plants. Identification of two classes with putative functions in redox homeostasis in Arabidopsis thaliana. J. Biol. Chem. 2002;277:30859–30869. doi: 10.1074/jbc.M202919200. [DOI] [PubMed] [Google Scholar]
  • 50.Foyer C.H., Noctor G. Ascorbate and glutathione: the heart of the redox hub. Plant Physiol. 2011;155:2–18. doi: 10.1104/pp.110.167569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kataya A.R.A., Reumann S. Arabidopsis glutathione reductase 1 is dually targeted to peroxisomes and the cytosol. Plant Signal. Behav. 2010;5:171–175. doi: 10.4161/PSB.5.2.10527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Horiguchi H., Yurimoto H., Kato N., Sakai Y. Antioxidant system within yeast peroxisome. Biochemical and physiological characterization of CbPmp20 in the methylotrophic yeast Candida boidinii. J. Biol. Chem. 2001;276:14279–14288. doi: 10.1074/jbc.M011661200. [DOI] [PubMed] [Google Scholar]
  • 53.Elbaz-Alon Y., Morgan B., Clancy A., Amoako T.N.E., Zalckvar E., Dick T.P., Schwappach B., Schuldiner M. The yeast oligopeptide transporter Opt2 is localized to peroxisomes and affects glutathione redox homeostasis. FEMS Yeast Res. 2014;14:1055–1067. doi: 10.1111/1567-1364.12196. [DOI] [PubMed] [Google Scholar]
  • 54.Park S.G., Cha M.K., Jeong W., Kim I.H. Distinct physiological functions of thiol peroxidase isoenzymes in Saccharomyces cerevisiae. J. Biol. Chem. 2000;275:5723–5732. doi: 10.1074/jbc.275.8.5723. [DOI] [PubMed] [Google Scholar]
  • 55.Tkach J.M., Yimit A., Lee A.Y., Riffle M., Costanzo M., Jaschob D., Hendry J.A., Ou J., Moffat J., Boone C., Davis T.N., Nislow C., Brown G.W. Dissecting DNA damage response pathways by analysing protein localization and abundance changes during DNA replication stress. Nat. Cell Biol. 2012;14:966–976. doi: 10.1038/ncb2549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Barreto L., Garcerá A., Jansson K., Sunnerhagen P., Herrero E. A peroxisomal glutathione transferase of Saccharomyces cerevisiae is functionally related to sulfur amino acid metabolism. Eukaryot. Cell. 2006;5:1748–1759. doi: 10.1128/EC.00216-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Yifrach E., Holbrook‐Smith D., Bürgi J., Othman A., Eisenstein M., van Roermund C.W., Visser W., Tirosh A., Rudowitz M., Bibi C., Galor S., Weill U., Fadel A., Peleg Y., Erdmann R., Waterham H.R., Wanders R.J.A., Wilmanns M., Zamboni N., Schuldiner M., Zalckvar E. Systematic multi-level analysis of an organelle proteome reveals new peroxisomal functions. Mol. Syst. Biol. 2022;18 doi: 10.15252/MSB.202211186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Garcerá A., Barreto L., Piedrafita L., Tamarit J., Herrero E. Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases. Biochem. J. 2006;398:187–196. doi: 10.1042/BJ20060034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Board P.G., Coggan M., Chelvanayagam G., Easteal S., Jermiin L.S., Schulte G.K., Danley D.E., Hoth L.R., Griffor M.C., V Kamath A., Rosner M.H., Chrunyk B.A., Perregaux D.E., Gabel C.A., Geoghegan K.F., Pandit J. Identification, characterization, and crystal structure of the Omega class glutathione transferases. J. Biol. Chem. 2000;275:24798–24806. doi: 10.1074/jbc.M001706200. [DOI] [PubMed] [Google Scholar]
  • 60.Ohdate T., Inoue Y. Involvement of glutathione peroxidase 1 in growth and peroxisome formation in Saccharomyces cerevisiae in oleic acid medium. Biochim. Biophys. Acta. 2012;1821:1295–1305. doi: 10.1016/j.bbalip.2012.05.004. [DOI] [PubMed] [Google Scholar]
  • 61.Breker M., Gymrek M., Moldavski O., Schuldiner M. LoQAtE--Localization and Quantitation ATlas of the yeast proteomE. A new tool for multiparametric dissection of single-protein behavior in response to biological perturbations in yeast. Nucleic Acids Res. 2014;42:D726–D730. doi: 10.1093/nar/gkt933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Jowsey I.R., Thomson R.E., Orton T.C., Elcombe C.R., Hayes J.D. Biochemical and genetic characterization of a murine class Kappa glutathione S-transferase. Biochem. J. 2003;373:559–569. doi: 10.1042/BJ20030415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Morel F., Aninat C. The glutathione transferase kappa family. Drug Metab. Rev. 2011;43:281–291. doi: 10.3109/03602532.2011.556122. [DOI] [PubMed] [Google Scholar]
  • 64.Fransen M., Lismont C. Peroxisomes and cellular oxidant/antioxidant balance: protein redox modifications and impact on inter-organelle communication. Subcell. Biochem. 2018;89:435–461. doi: 10.1007/978-981-13-2233-4_19. [DOI] [PubMed] [Google Scholar]
  • 65.Wang B., Van Veldhoven P.P., Brees C., Rubio N., Nordgren M., Apanasets O., Kunze M., Baes M., Agostinis P., Fransen M. Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells. Free Radic. Biol. Med. 2013;65:882–894. doi: 10.1016/j.freeradbiomed.2013.08.173. [DOI] [PubMed] [Google Scholar]
  • 66.Costa C.F., Lismont C., Chornyi S., Li H., Hussein M.A.F., Waterham H.R., Fransen M. vol. 12. Antioxidants; Basel, Switzerland: 2023. (Functional Analysis of GSTK1 in Peroxisomal Redox Homeostasis in HEK-293 Cells). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Antonenkov V.D., Hiltunen J.K. Peroxisomal membrane permeability and solute transfer. Biochim. Biophys. Acta. 2006;1763:1697–1706. doi: 10.1016/j.bbamcr.2006.08.044. [DOI] [PubMed] [Google Scholar]
  • 68.Antonenkov V.D., Hiltunen J.K. Transfer of metabolites across the peroxisomal membrane. Biochim. Biophys. Acta. 2012;1822:1374–1386. doi: 10.1016/j.bbadis.2011.12.011. [DOI] [PubMed] [Google Scholar]
  • 69.Chornyi S., Ijlst L., van Roermund C.W.T., Wanders R.J.A., Waterham H.R. Peroxisomal metabolite and cofactor transport in humans. Front. Cell Dev. Biol. 2020;8 doi: 10.3389/fcell.2020.613892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Dias A.F., Francisco T., Rodrigues T.A., Grou C.P., Azevedo J.E. The first minutes in the life of a peroxisomal matrix protein. Biochim. Biophys. Acta Mol. Cell Res. 2016;1863:814–820. doi: 10.1016/j.bbamcr.2015.09.025. [DOI] [PubMed] [Google Scholar]
  • 71.Agrimi G., Russo A., Scarcia P., Palmieri F. The human gene SLC25A17 encodes a peroxisomal transporter of coenzyme A, FAD and NAD+ Biochem. J. 2012;443:241–247. doi: 10.1042/BJ20111420. [DOI] [PubMed] [Google Scholar]
  • 72.Visser W.F., van Roermund C.W.T., Waterham H.R., Wanders R.J.A. Identification of human PMP34 as a peroxisomal ATP transporter. Biochem. Biophys. Res. Commun. 2002;299:494–497. doi: 10.1016/s0006-291x(02)02663-3. [DOI] [PubMed] [Google Scholar]
  • 73.van Roermund C.W.T., Visser W.F., Ijlst L., Van Cruchten A., Boek M., Kulik W., Waterham H.R., Wanders R.J. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. Faseb. J. 2008;22:4201–4208. doi: 10.1096/fj.08-110866. [DOI] [PubMed] [Google Scholar]
  • 74.Fourcade S., Ruiz M., Camps C., Schlüter A., Houten S.M., Mooyer P.A.W., Pàmpols T., Dacremont G., Wanders R.J.A., Giròs M., Pujol A. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am. J. Physiol. Endocrinol. Metab. 2009;296:E211–E221. doi: 10.1152/ajpendo.90736.2008. [DOI] [PubMed] [Google Scholar]
  • 75.van Roermund C.W.T., Ijlst L., Wagemans T., Wanders R.J.A., Waterham H.R. A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. Biochim. Biophys. Acta. 2014;1841:563–568. doi: 10.1016/j.bbalip.2013.12.001. [DOI] [PubMed] [Google Scholar]
  • 76.van Roermund C.W.T.T., Visser W.F., Ijlst L., Waterham H.R., Wanders R.J.A. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation. Biochim. Biophys. Acta. 2011;1811:148–152. doi: 10.1016/j.bbalip.2010.11.010. [DOI] [PubMed] [Google Scholar]
  • 77.DeLoache W.C., Russ Z.N., Dueber J.E. Towards repurposing the yeast peroxisome for compartmentalizing heterologous metabolic pathways. Nat. Commun. 2016;7 doi: 10.1038/ncomms11152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Landowski M., Bhute V.J., Grindel S., Haugstad Z., Gyening Y.K., Tytanic M., Brush R.S., Moyer L.J., Nelson D.W., Davis C.R., Yen C.-L.E., Ikeda S., Agbaga M.-P., Ikeda A. Transmembrane protein 135 regulates lipid homeostasis through its role in peroxisomal DHA metabolism. Commun. Biol. 2023;6:8. doi: 10.1038/s42003-022-04404-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Vapola M.H., Rokka A., Sormunen R.T., Alhonen L., Schmitz W., Conzelmann E., Wärri A., Grunau S., Antonenkov V.D., Hiltunen J.K. Peroxisomal membrane channel Pxmp2 in the mammary fat pad is essential for stromal lipid homeostasis and for development of mammary gland epithelium in mice. Dev. Biol. 2014;391:66–80. doi: 10.1016/j.ydbio.2014.03.022. [DOI] [PubMed] [Google Scholar]
  • 80.Lismont C., Koster J., Provost S., Baes M., Van Veldhoven P.P., Waterham H.R., Fransen M. Deciphering the potential involvement of PXMP2 and PEX11B in hydrogen peroxide permeation across the peroxisomal membrane reveals a role for PEX11B in protein sorting. Biochim. Biophys. Acta Biomembr. 2019;1861 doi: 10.1016/j.bbamem.2019.05.013. [DOI] [PubMed] [Google Scholar]
  • 81.Blankestijn M., Bloks V.W., Struik D., Huijkman N., Kloosterhuis N., Wolters J.C., Wanders R.J.A., Vaz F.M., Islinger M., Kuipers F., van de Sluis B., Groen A.K., Verkade H.J., Jonker J.W. Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism. Sci. Rep. 2022;12:2512. doi: 10.1038/s41598-022-06479-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Van Veldhoven P.P., de Schryver E., Young S.G., Zwijsen A., Fransen M., Espeel M., Baes M., Van Ael E. Slc25a17 gene trapped mice: PMP34 plays a role in the peroxisomal degradation of phytanic and pristanic acid. Front. Cell Dev. Biol. 2020;8:144. doi: 10.3389/fcell.2020.00144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Li X., Baumgart E., Dong G.-X., Morrell J.C., Jimenez-Sanchez G., Valle D., Smith K.D., Gould S.J. PEX11alpha is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation. Mol. Cell Biol. 2002;22:8226–8240. doi: 10.1128/MCB.22.23.8226-8240.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Lu J.F., Lawler A.M., Watkins P.A., Powers J.M., Moser A.B., Moser H.W., Smith K.D. A mouse model for X-linked adrenoleukodystrophy. Proc. Natl. Acad. Sci. U.S.A. 1997;94:9366–9371. doi: 10.1073/pnas.94.17.9366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Ferrer I., Kapfhammer J.P., Hindelang C., Kemp S., Troffer-Charlier N., Broccoli V., Callyzot N., Mooyer P., Selhorst J., Vreken P., Wanders R.J.A., Mandel J.L., Pujol A. Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Hum. Mol. Genet. 2005;14:3565–3577. doi: 10.1093/hmg/ddi384. [DOI] [PubMed] [Google Scholar]
  • 86.Ferdinandusse S., Jimenez-Sanchez G., Koster J., Denis S., Van Roermund C.W., Silva-Zolezzi I., Moser A.B., Visser W.F., Gulluoglu M., Durmaz O., Demirkol M., Waterham H.R., Gökcay G., Wanders R.J.A., Valle D. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. Hum. Mol. Genet. 2015;24:361–370. doi: 10.1093/hmg/ddu448. [DOI] [PubMed] [Google Scholar]
  • 87.Dias A.F., Rodrigues T.A., Pedrosa A.G., Barros-Barbosa A., Francisco T., Azevedo J.E. The peroxisomal matrix protein translocon is a large cavity-forming protein assembly into which PEX5 protein enters to release its cargo. J. Biol. Chem. 2017;292:15287–15300. doi: 10.1074/jbc.M117.805044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Gao Y., Skowyra M.L., Feng P., Rapoport T.A. Protein import into peroxisomes occurs through a nuclear pore-like phase. Science. 2022;378 doi: 10.1126/science.adf3971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Turkolmez S., Chornyi S., Alhajouj S., Ijlst L., Waterham H.R., Mitchell P.J., Hettema E.H., van Roermund C.W.T. Peroxisomal NAD(H) homeostasis in the yeast Debaryomyces hansenii depends on two redox shuttles and the NAD+ carrier, Pmp47. Biomolecules. 2023;13:1294. doi: 10.3390/biom13091294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Topf U., Suppanz I., Samluk L., Wrobel L., Böser A., Sakowska P., Knapp B., Pietrzyk M.K., Chacinska A., Warscheid B. Quantitative proteomics identifies redox switches for global translation modulation by mitochondrially produced reactive oxygen species. Nat. Commun. 2018;9:324. doi: 10.1038/s41467-017-02694-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Rosenwasser S., Rot I., Sollner E., Meyer A.J., Smith Y., Leviatan N., Fluhr R., Friedman H. Organelles contribute differentially to reactive oxygen species-related events during extended darkness. Plant Physiol. 2011;156:185–201. doi: 10.1104/pp.110.169797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Bratt A., Rosenwasser S., Meyer A., Fluhr R. Organelle redox autonomy during environmental stress. Plant Cell Environ. 2016;39:1909. doi: 10.1111/pce.12746. –19. [DOI] [PubMed] [Google Scholar]
  • 93.Schwarzländer M., Fricker M.D., Müller C., Marty L., Brach T., Novak J., Sweetlove L.J., Hell R., Meyer A.J. Confocal imaging of glutathione redox potential in living plant cells. J. Microsc. 2008;231:299–316. doi: 10.1111/j.1365-2818.2008.02030.x. [DOI] [PubMed] [Google Scholar]
  • 94.Menon D., Board P.G. A role for glutathione transferase Omega 1 (GSTO1-1) in the glutathionylation cycle. J. Biol. Chem. 2013;288:25769–25779. doi: 10.1074/jbc.M113.487785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Caccuri A.M., Antonini G., Allocati N., Di Ilio C., De Maria F., Innocenti F., Parker M.W., Masulli M., Lo Bello M., Turella P., Federici G., Ricci G. GSTB1-1 from Proteus mirabilis: a snapshot of an enzyme in the evolutionary pathway from a redox enzyme to a conjugating enzyme. J. Biol. Chem. 2002;277 doi: 10.1074/jbc.M201137200. 18777–84. [DOI] [PubMed] [Google Scholar]
  • 96.Zahedi Avval F., Holmgren A. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase. J. Biol. Chem. 2009;284:8233–8240. doi: 10.1074/jbc.M809338200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Rouhier N., Couturier J., Jacquot J.-P. Genome-wide analysis of plant glutaredoxin systems. J. Exp. Bot. 2006;57:1685–1696. doi: 10.1093/jxb/erl001. [DOI] [PubMed] [Google Scholar]
  • 98.Rouhier N., Gelhaye E., Jacquot J.-P. Plant glutaredoxins: still mysterious reducing systems. Cell. Mol. Life Sci. 2004;61:1266–1277. doi: 10.1007/s00018-004-3410-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Deng Q., Li H., Feng Y., Xu R., Li W., Zhu R., Akhter D., Shen X., Hu J., Jiang H., Pan R. Defining upstream enhancing and inhibiting sequence patterns for plant peroxisome targeting signal type 1 using large-scale in silico and in vivo analyses. Plant J. 2022;111:567–582. doi: 10.1111/tpj.15840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Zhang Z.-R., Perrett S. Novel glutaredoxin activity of the yeast prion protein Ure2 reveals a native-like dimer within fibrils. J. Biol. Chem. 2009;284:14058–14067. doi: 10.1074/jbc.M901189200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Blackburn A.C., Coggan M., Shield A.J., Cappello J., Theodoratos A., Murray T.P., Rooke M., Larter C.Z., Koina M.E., Dahlstrom J.E., Matthaei K.I., Board P.G. Glutathione transferase kappa deficiency causes glomerular nephropathy without overt oxidative stress. Lab. Invest. 2011;91:1572–1583. doi: 10.1038/labinvest.2011.107. [DOI] [PubMed] [Google Scholar]
  • 102.Nagy P. Kinetics and mechanisms of thiol–disulfide exchange covering direct substitution and thiol oxidation-mediated pathways. Antioxidants Redox Signal. 2013;18:1623–1641. doi: 10.1089/ars.2012.4973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613–619. doi: 10.1016/j.redox.2016.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Turell L., Botti H., Carballal S., Ferrer-Sueta G., Souza J.M., Durán R., Freeman B.A., Radi R., Alvarez B. Reactivity of sulfenic acid in human serum albumin. Biochemistry. 2008;47:358–367. doi: 10.1021/bi701520y. [DOI] [PubMed] [Google Scholar]
  • 105.Chang T.-S., Jeong W., Woo H.A., Lee S.M., Park S., Rhee S.G. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 2004;279:50994–51001. doi: 10.1074/jbc.M409482200. [DOI] [PubMed] [Google Scholar]
  • 106.Sohn J., Rudolph J. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry. 2003;42:10060–10070. doi: 10.1021/BI0345081. [DOI] [PubMed] [Google Scholar]
  • 107.Semelak J.A., Battistini F., Radi R., Trujillo M., Zeida A., Estrin D.A. Multiscale modeling of thiol overoxidation in peroxiredoxins by hydrogen peroxide. J. Chem. Inf. Model. 2020;60:843–853. doi: 10.1021/acs.jcim.9b00817. [DOI] [PubMed] [Google Scholar]
  • 108.Oshino N., Jamieson D., Sugano T., Chance B. Optical measurement of the catalase-hydrogen peroxide intermediate (Compound I) in the liver of anaesthetized rats and its implication to hydrogen peroxide production in situ. Biochem. J. 1975;146:67–77. doi: 10.1042/BJ1460067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Wang Z., O'Connor T.P., Heshka S., Heymsfield S.B. The reconstruction of Kleiber's law at the organ-tissue level. J. Nutr. 2001;131:2967–2970. doi: 10.1093/jn/131.11.2967. [DOI] [PubMed] [Google Scholar]
  • 110.Gabaldón T. Peroxisome diversity and evolution. Philos. Trans. R. Soc. 2010;365:765–773. doi: 10.1098/rstb.2009.0240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Islinger M., Cardoso M.J.R., Schrader M. Be different--the diversity of peroxisomes in the animal kingdom. Biochim. Biophys. Acta. 2010;1803:881–897. doi: 10.1016/j.bbamcr.2010.03.013. [DOI] [PubMed] [Google Scholar]
  • 112.Góth L., Eaton J.W. Hereditary catalase deficiencies and increased risk of diabetes. Lancet (London, England) 2000;356:1820. doi: 10.1016/S0140-6736(00)03238-4. –1. [DOI] [PubMed] [Google Scholar]
  • 113.Ho Y.-S.S., Xiong Y., Ma W., Spector A., Ho D.S. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J. Biol. Chem. 2004;279:32804–32812. doi: 10.1074/jbc.M404800200. [DOI] [PubMed] [Google Scholar]
  • 114.Enayetallah A.E., French R.A., Barber M., Grant D.F. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues. J. Histochem. Cytochem. 2006;54:329–335. doi: 10.1369/jhc.5A6808.2005. [DOI] [PubMed] [Google Scholar]
  • 115.Winterbourn C.C., Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic. Biol. Med. 1999;27:322–328. doi: 10.1016/s0891-5849(99)00051-9. [DOI] [PubMed] [Google Scholar]
  • 116.Nemoto N., Gelboin H. Assay and properties of glutathione-S-benzo(a)pyrene-4,5-oxide transferase. Arch. Biochem. Biophys. 1975;170:739–742. doi: 10.1016/0003-9861(75)90172-1. [DOI] [PubMed] [Google Scholar]
  • 117.Dubuisson M., Vander Stricht D., Clippe A., Etienne F., Nauser T., Kissner R., Koppenol W.H., Rees J.-F.F., Knoops B. Human peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett. 2004;571:161–165. doi: 10.1016/j.febslet.2004.06.080. [DOI] [PubMed] [Google Scholar]
  • 118.Knoops B., Goemaere J., Van Der Eecken V., Declercq J.-P.P. Peroxiredoxin 5: structure, mechanism, and function of the mammalian atypical 2-cys peroxiredoxin. Antioxidants Redox Signal. 2011;15:817–829. doi: 10.1089/ars.2010.3584. [DOI] [PubMed] [Google Scholar]
  • 119.Banmeyer I., Marchand C., Verhaeghe C., Vucic B., Rees J.-F., Knoops B. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic. Biol. Med. 2004;36:65–77. doi: 10.1016/j.freeradbiomed.2003.10.019. [DOI] [PubMed] [Google Scholar]
  • 120.Rhee S.G., Kil I.S. Multiple functions and regulation of mammalian peroxiredoxins. Annu. Rev. Biochem. 2017;86:749–775. doi: 10.1146/annurev-biochem-060815-014431. [DOI] [PubMed] [Google Scholar]
  • 121.Reumann S., Babujee L., Ma C., Wienkoop S., Siemsen T., Antonicelli G.E., Rasche N., Lüder F., Weckwerth W., Jahn O. Proteome analysis of Arabidopsis leaf peroxisomes reveals novel targeting peptides, metabolic pathways, and defense mechanisms. Plant Cell. 2007;19:3170–3193. doi: 10.1105/tpc.107.050989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Kliebenstein D.J., Monde R.A., Last R.L. Superoxide dismutase in Arabidopsis: an eclectic enzyme family with disparate regulation and protein localization. Plant Physiol. 1998;118:637–650. doi: 10.1104/pp.118.2.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Keller G.A., Warner T.G., Steimer K.S., Hallewell R.A. Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. Proc. Natl. Acad. Sci. U.S.A. 1991;88:7381–7385. doi: 10.1073/pnas.88.16.7381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Fukao Y., Hayashi M., Nishimura M. Proteomic analysis of leaf peroxisomal proteins in greening cotyledons of Arabidopsis thaliana. Plant Cell Physiol. 2002;43:689–696. doi: 10.1093/pcp/pcf101. [DOI] [PubMed] [Google Scholar]
  • 125.Al-Hajaya Y., Karpinska B., Foyer C.H., Baker A. Nuclear and peroxisomal targeting of catalase. Plant Cell Environ. 2022;45:1096–1108. doi: 10.1111/pce.14262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Purdue P.E., Lazarow P.B. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J. Cell Biol. 1996;134:849–862. doi: 10.1083/jcb.134.4.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Trelease R.N., Xie W., Lee M.S., Mullen R.T. Rat liver catalase is sorted to peroxisomes by its C-terminal tripeptide Ala-Asn-Leu, not by the internal Ser-Lys-Leu motif. Eur. J. Cell Biol. 1996;71:248–258. http://www.ncbi.nlm.nih.gov/pubmed/8929563 [PubMed] [Google Scholar]
  • 128.Patel B.N., Mackness M.I., Nwosu V., Connock M.J. Subcellular localization of epoxide hydrolase in mouse liver and kidney. Biochem. Pharmacol. 1986;35:231–235. doi: 10.1016/0006-2952(86)90519-8. [DOI] [PubMed] [Google Scholar]
  • 129.Schladt L., Wörner W., Setiabudi F., Oesch F. Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats. Biochem. Pharmacol. 1986;35:3309–3316. doi: 10.1016/0006-2952(86)90428-4. [DOI] [PubMed] [Google Scholar]
  • 130.Narendra S., Venkataramani S., Shen G., Wang J., Pasapula V., Lin Y., Kornyeyev D., Holaday A.S., Zhang H. The Arabidopsis ascorbate peroxidase 3 is a peroxisomal membrane-bound antioxidant enzyme and is dispensable for Arabidopsis growth and development. J. Exp. Bot. 2006;57:3033–3042. doi: 10.1093/jxb/erl060. [DOI] [PubMed] [Google Scholar]
  • 131.Lisenbee C.S., Lingard M.J., Trelease R.N. Arabidopsis peroxisomes possess functionally redundant membrane and matrix isoforms of monodehydroascorbate reductase. Plant J. 2005;43:900–914. doi: 10.1111/j.1365-313X.2005.02503.x. [DOI] [PubMed] [Google Scholar]
  • 132.Seth D., Rudolph J. Redox regulation of MAP kinase phosphatase 3. Biochemistry. 2006;45:8476–8487. doi: 10.1021/BI060157P. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No data was used for the research described in the article.


Articles from Redox Biology are provided here courtesy of Elsevier

RESOURCES